Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients

• Status: Suspended
• Trial end date: 2022-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the analgesic effects of cannabidiol for patients who have undergone simple tooth extraction. Participants will be randomized to one of four arms: treatment-as-usual (TAU), cannabidiol 17mg/mL, cannabidiol 37mg/mL, or placebo.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Tennessee
• Treatments: Acetaminophen; Analgesics; Cannabidiol; Epidiolex; Ibuprofen

Criteria

Inclusion Criteria:

• Presenting for an operatory appointment at University of Tennessee Health Science Center College of Dentistry Oral and Maxillofacial Surgery Department

• Operation must be a simple tooth extraction which does not result in an opioid prescription

• 18 years of age or older

• Have regular and direct access to a device that can send and receive texts and willing to accept any associated charges for 24 text messages

Exclusion Criteria:

• Contraindication to ibuprofen

• Contraindication to acetaminophen

• Contraindication to cannabidiol or hemp oil

• Contraindication to peppermint oil

• Contraindication to almond or other tree nuts

• Currently taking a form of cannabidiol and unwilling to stop use for one week post surgery